Drug search by name

Dipyridamole Oral, Intravenous and Bronchospasm

Result of checking the interaction of drug Dipyridamole Oral, Intravenous and disease Bronchospasm for safety when used together.

Check result:

Dipyridamole Oral, Intravenous <> Bronchospasm

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Dipyridamole is a phosphodiesterase inhibitor and can exacerbate bronchospasm, particularly in patients with reactive airway disease and/or chronic obstructive pulmonary disease (COPD). Therapy with dipyridamole is contraindicated in patients with active wheezing and should be administered cautiously in patients with asthma or COPD.

References:

Lette J, Cerino M, Laverdiere M, Tremblay J, Prenovault J "Severe bronchospasm followed by respiratory arrest during thallium- dipyridamole imaging." Chest 95 (1989): 1345-7
"Product Information. Persantine (dipyridamole)." Boehringer-Ingelheim, Ridgefield, CT.
Eagle KA, Boucher CA "Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patients." Chest 95 (1989): 258-9

Dipyridamole Oral, Intravenous

Generic Name: dipyridamole

Brand Name: Persantine, Persantine IV

Synonyms: Dipyridamole

What is Dipyridamole Oral, Intravenous?